Perigon Wealth Management, LLC Biogen Inc. Transaction History

Perigon Wealth Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	BUY	$275.25 - $318.06 $216,621 - $250,313	787 New	787 $224,000
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $74,585 - $87,381	-307 Closed	0 $0
Q4 2020 Jan 28, 2021	BUY	$236.26 - $355.63 $72,531 - $109,178	307 New	307 $75,000
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $166,866 - $260,999	-770 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$278.5 - $352.75 $130,895 - $165,792	-470 Reduced 37.9%	770 $259,000
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $91,281 - $119,371	-311 Reduced 20.05%	1,240 $438,000
Q2 2018 Aug 09, 2018	BUY	$257.52 - $306.91 $146,786 - $174,938	570 Added 58.1%	1,551 $450,000
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $245,042 - $346,571	942 Added 2415.38%	981 $269,000
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $289,489 - $324,249	-941 Reduced 96.02%	39 $12,000
Q3 2017 Dec 05, 2017	BUY	$281.15 - $329.69 $275,527 - $323,096	980	980 $307,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Perigon Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Perigon Wealth Management, LLC with notifications on news.